Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Float Short %

11.13

Margin Of Safety %

Put/Call OI Ratio

0.35

EPS Next Q Diff

0.28

EPS Last/This Y

EPS This/Next Y

0.29

Price

14.92

Target Price

14.96

Analyst Recom

2.44

Performance Q

32.8

Relative Volume

1.19

Beta

0.62

Ticker: BLCO




21 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-07-25BLCO14.30.350.0211495
2025-07-28BLCO14.450.350.0911538
2025-07-29BLCO14.670.350.2011576
2025-07-30BLCO13.720.350.1211639
2025-07-31BLCO13.650.350.3611716
2025-08-01BLCO13.50.350.0211748
2025-08-04BLCO13.740.350.0111719
2025-08-05BLCO14.450.350.0411810
2025-08-06BLCO14.120.350.0011841
2025-08-07BLCO13.760.350.0011881
2025-08-08BLCO13.650.340.0011922
2025-08-11BLCO13.650.350.0011899
2025-08-12BLCO13.770.340.0011981
2025-08-13BLCO14.160.340.0012161
2025-08-14BLCO14.10.330.0012172
2025-08-15BLCO14.540.330.3812232
2025-08-18BLCO14.470.331.6510656
2025-08-19BLCO14.640.350.0010868
2025-08-20BLCO14.550.350.0010884
2025-08-21BLCO14.50.350.0010890
2025-08-22BLCO14.930.350.0010916
DateSymbolLastP/C OIP/C VolTotal OI
21 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-07-25BLCO14.32-33.0- 0.45
2025-07-28BLCO14.52-33.0- 0.45
2025-07-29BLCO14.65-35.2- 0.45
2025-07-30BLCO13.71-35.2- 0.45
2025-07-31BLCO13.63-35.2- 0.45
2025-08-01BLCO13.50-9.4- 0.50
2025-08-04BLCO13.72-9.4- 0.50
2025-08-05BLCO14.44-9.4- 0.50
2025-08-06BLCO14.12-3.3-16.90.50
2025-08-07BLCO13.80-3.3- 0.50
2025-08-08BLCO13.64-3.3- 0.49
2025-08-11BLCO13.65-3.3- 0.49
2025-08-12BLCO13.77-3.3- 0.49
2025-08-13BLCO14.17-3.3- 0.49
2025-08-14BLCO14.10-3.3- 0.49
2025-08-15BLCO14.55-3.3- 0.49
2025-08-18BLCO14.47-3.3- 0.49
2025-08-19BLCO14.61-3.3- 0.49
2025-08-20BLCO14.55-3.6- 0.49
2025-08-21BLCO14.50-3.6- 0.49
2025-08-22BLCO14.92-3.3- 0.49
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-07-25BLCO0.017.6311.28
2025-07-28BLCO0.018.1011.28
2025-07-29BLCO0.018.1011.28
2025-07-30BLCO0.018.1011.28
2025-07-31BLCO0.018.1011.28
2025-08-01BLCO0.018.1011.28
2025-08-04BLCO0.016.7011.26
2025-08-05BLCO0.016.7011.26
2025-08-06BLCO0.016.7011.26
2025-08-07BLCO0.016.7011.26
2025-08-08BLCO0.016.7011.26
2025-08-11BLCO0.016.7111.26
2025-08-12BLCO0.016.7111.11
2025-08-13BLCO0.016.7111.13
2025-08-14BLCO0.016.7111.13
2025-08-15BLCO0.016.7111.13
2025-08-18BLCO0.013.9611.13
2025-08-19BLCO0.013.9611.13
2025-08-20BLCO0.013.9611.13
2025-08-21BLCO0.013.9611.13
2025-08-22BLCO0.013.9611.13
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS

0.07

Avg. EPS Est. Current Quarter

0.16

Avg. EPS Est. Next Quarter

0.35

Insider Transactions

0.01

Institutional Transactions

3.96

Beta

0.62

Average Sales Estimate Current Quarter

1276

Average Sales Estimate Next Quarter

1388

Fair Value

Quality Score

53

Growth Score

68

Sentiment Score

91

Actual DrawDown %

32

Max Drawdown 5-Year %

Target Price

14.96

P/E

Forward P/E

18.86

PEG

P/S

1.08

P/B

0.82

P/Free Cash Flow

EPS

-0.77

Average EPS Est. Cur. Y​

0.49

EPS Next Y. (Est.)

0.78

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-5.58

Relative Volume

1.19

Return on Equity vs Sector %

-29

Return on Equity vs Industry %

-13.1

EPS 1 7Days Diff

EPS 1 30Days Diff

0.03

EBIT Estimation

Bausch + Lomb Corporation
Sector: Healthcare
Industry: Medical Instruments & Supplies
Employees: 13500
Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lenses that are indicated for therapeutic use and provides optical correction during healing. It also offers contact lens care products, eye vitamins, mineral supplements, and over-the-counter eye drops that address various conditions, such as eye allergies, conjunctivitis, dry eye, and redness relief. The Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of glaucoma, eye inflammation, ocular hypertension, dry eyes, and retinal diseases. The Surgical segment provides medical device equipment, consumables, and technologies for the treatment of cataracts, corneal, vitreous, and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices for cataract surgery. The company sells its products and services through direct sales forces and independent distributors. Bausch + Lomb Corporation was founded in 1853 and is headquartered in Vaughan, Canada. Bausch + Lomb Corporation operates as a subsidiary of Bausch Health Companies Inc.
stock quote shares BLCO – Bausch + Lomb Corporation Stock Price stock today
news today BLCO – Bausch + Lomb Corporation stock forecast ,stock prediction 2023 2024 2025
marketwatch BLCO – Bausch + Lomb Corporation yahoo finance google finance
stock history BLCO – Bausch + Lomb Corporation invest stock market
stock prices BLCO premarket after hours
ticker BLCO fair value insiders trading